Cronin KA, Scott S, Firth AU, et al. Annual report to the nation on the status of cancer, part 1: national cancer statistics. Cancer 2022;128:4251–4284.

• PubMed
Cronin KA, Scott S, Firth AU, Annual report to the nation on the status of cancer, part 1: national cancer statistics. Cancer 2022;128:4251–4284.)| false
• Search Google Scholar
• Export Citation

Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. CA Cancer J Clin 2023;73:17–48.

• PubMed
Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. CA Cancer J Clin 2023;73:17–48.)| false
• Search Google Scholar
• Export Citation

Jemal A, Ward EM, Johnson CJ, et al. Annual report to the nation on the status of cancer, 1975–2014, featuring survival. J Natl Cancer Inst 2017;109:djx030.

• PubMed
Jemal A, Ward EM, Johnson CJ, Annual report to the nation on the status of cancer, 1975–2014, featuring survival. J Natl Cancer Inst 2017;109:djx030.)| false
• Search Google Scholar
• Export Citation

Aberle DR, Berg CD, Black WC, et al. The National Lung Screening Trial: overview and study design. Radiology 2011;258:243–253.

• PubMed
Aberle DR, Berg CD, Black WC, The National Lung Screening Trial: overview and study design. Radiology 2011;258:243–253.)| false
• Search Google Scholar
• Export Citation

de Koning HJ, van der Aalst CM, de Jong PA, et al. Reduced lung-cancer mortality with volume CT screening in a randomized trial. N Engl J Med 2020;382:503–513.

• PubMed
de Koning HJ, van der Aalst CM, de Jong PA, Reduced lung-cancer mortality with volume CT screening in a randomized trial. N Engl J Med 2020;382:503–513.)| false
• Search Google Scholar
• Export Citation

Potter AL, Rosenstein AL, Kiang MV, et al. Association of computed tomography screening with lung cancer stage shift and survival in the United States: quasi-experimental study. BMJ 2022;376:e069008.

• PubMed
Potter AL, Rosenstein AL, Kiang MV, Association of computed tomography screening with lung cancer stage shift and survival in the United States: quasi-experimental study. BMJ 2022;376:e069008.)| false
• Search Google Scholar
• Export Citation

Aberle DR, Black WC, Chiles C, et al. Lung cancer incidence and mortality with extended follow-up in the National Lung Screening Trial. J Thorac Oncol 2019;14:1732–1742.

• PubMed
Aberle DR, Black WC, Chiles C, Lung cancer incidence and mortality with extended follow-up in the National Lung Screening Trial. J Thorac Oncol 2019;14:1732–1742.)| false
• Search Google Scholar
• Export Citation

Aberle DR, DeMello S, Berg CD, et al. Results of the two incidence screenings in the National Lung Screening Trial. N Engl J Med 2013;369:920–931.

• PubMed
Aberle DR, DeMello S, Berg CD, Results of the two incidence screenings in the National Lung Screening Trial. N Engl J Med 2013;369:920–931.)| false
• Search Google Scholar
• Export Citation

Krist AH, Davidson KW, Mangione CM, et al. Screening for lung cancer: US Preventive Services Task Force recommendation statement. JAMA 2021;325:962–970.

• PubMed
Krist AH, Davidson KW, Mangione CM, Screening for lung cancer: US Preventive Services Task Force recommendation statement. JAMA 2021;325:962–970.)| false
• Search Google Scholar
• Export Citation

Moyer VA. Screening for lung cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2014;160:330–338.

• PubMed
Moyer VA. Screening for lung cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2014;160:330–338.)| false
• Search Google Scholar
• Export Citation

Henderson LM, Su IH, Rivera MP, et al. Prevalence of lung cancer screening in the US, 2022. JAMA Netw Open 2024;7:e243190.

• PubMed
Henderson LM, Su IH, Rivera MP, Prevalence of lung cancer screening in the US, 2022. JAMA Netw Open 2024;7:e243190.)| false
• Search Google Scholar
• Export Citation

Bandi P, Star J, Ashad-Bishop K, et al. Lung cancer screening in the US, 2022. JAMA Intern Med 2024;184:882–891.

• PubMed
Bandi P, Star J, Ashad-Bishop K, Lung cancer screening in the US, 2022. JAMA Intern Med 2024;184:882–891.)| false
• Search Google Scholar
• Export Citation

Vachani A, Carroll NM, Simoff MJ, et al. Stage migration and lung cancer incidence after initiation of low-dose computed tomography screening. J Thorac Oncol 2022;17:1355–1364.

• PubMed
Vachani A, Carroll NM, Simoff MJ, Stage migration and lung cancer incidence after initiation of low-dose computed tomography screening. J Thorac Oncol 2022;17:1355–1364.)| false
• Search Google Scholar
• Export Citation

Flores R, Patel P, Alpert N, et al. Association of stage shift and population mortality among patients with non-small cell lung cancer. JAMA Netw Open 2021;4:e2137508.

• PubMed
Flores R, Patel P, Alpert N, Association of stage shift and population mortality among patients with non-small cell lung cancer. JAMA Netw Open 2021;4:e2137508.)| false
• Search Google Scholar
• Export Citation

Wood DE, Eapen GA, Ettinger DS, et al. Lung cancer screening. J Natl Compr Canc Netw 2012;10:240–265.

• PubMed
Wood DE, Eapen GA, Ettinger DS, Lung cancer screening. J Natl Compr Canc Netw 2012;10:240–265.)| false
• Search Google Scholar
• Export Citation

Neacşu F, Vârban AŞ, Simion G, et al. Lung cancer mimickers—a case series of seven patients and review of the literature. Rom J Morphol Embryol 2021;62:697–704.

• PubMed
Neacşu F, Vârban AŞ, Simion G, Lung cancer mimickers—a case series of seven patients and review of the literature. Rom J Morphol Embryol 2021;62:697–704.)| false
• Search Google Scholar
• Export Citation

Grunewald J, Grutters JC, Arkema EV, et al. Sarcoidosis. Nat Rev Dis Primers 2019;5:45.

• PubMed
Grunewald J, Grutters JC, Arkema EV, Sarcoidosis. Nat Rev Dis Primers 2019;5:45.)| false
• Search Google Scholar
• Export Citation

Pinsky PF, Dunn B, Gierada D, et al. Incidental renal tumours on low-dose CT lung cancer screening exams. J Med Screen 2017;24:104–109.

• PubMed
Pinsky PF, Dunn B, Gierada D, Incidental renal tumours on low-dose CT lung cancer screening exams. J Med Screen 2017;24:104–109.)| false
• Search Google Scholar
• Export Citation

Gould MK, Donington J, Lynch WR, et al. Evaluation of individuals with pulmonary nodules: when is it lung cancer? Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 2013;143:e93S–120S.

• PubMed
Gould MK, Donington J, Lynch WR, Evaluation of individuals with pulmonary nodules: when is it lung cancer? Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 2013;143:e93S–120S.)| false
• Search Google Scholar
• Export Citation

Murrmann GB, van Vollenhoven FH, Moodley L. Approach to a solid solitary pulmonary nodule in two different settings – “Common is common, rare is rare.” J Thorac Dis 2014;6:237–248.

• PubMed
Murrmann GB, van Vollenhoven FH, Moodley L. Approach to a solid solitary pulmonary nodule in two different settings – “Common is common, rare is rare.” J Thorac Dis 2014;6:237–248.)| false
• Search Google Scholar
• Export Citation

Dyer DS, White C, Conley Thomson C, et al. A quick reference guide for incidental findings on lung cancer screening CT examinations. J Am Coll Radiol 2023;20:162–172.

• PubMed
Dyer DS, White C, Conley Thomson C, A quick reference guide for incidental findings on lung cancer screening CT examinations. J Am Coll Radiol 2023;20:162–172.)| false
• Search Google Scholar
• Export Citation

Field JK, Smith RA, Aberle DR, et al. International Association for the Study of Lung Cancer computed tomography screening workshop 2011 report. J Thorac Oncol 2012;7:10–19.

• PubMed
Field JK, Smith RA, Aberle DR, International Association for the Study of Lung Cancer computed tomography screening workshop 2011 report. J Thorac Oncol 2012;7:10–19.)| false
• Search Google Scholar
• Export Citation

Mazzone PJ, Silvestri GA, Souter LH, et al. Screening for lung cancer: CHEST guideline and expert panel report. Chest 2021;160:e427–494.

• PubMed
Mazzone PJ, Silvestri GA, Souter LH, Screening for lung cancer: CHEST guideline and expert panel report. Chest 2021;160:e427–494.)| false
• Search Google Scholar
• Export Citation

Centers for Medicare and Medicaid Services (CMS). Screening for lung cancer with low dose computed tomography (LDCT). Accessed November 21, 2022. Available at: https://www.cms.gov/medicare-coverage-database/view/ncacal-decision-memo.aspx?proposed=N&ncaid=304

• PubMed
Centers for Medicare and Medicaid Services (CMS). Screening for lung cancer with low dose computed tomography (LDCT). Accessed November 21, 2022. Available at: https://www.cms.gov/medicare-coverage-database/view/ncacal-decision-memo.aspx?proposed=N&ncaid=304)| false
• Search Google Scholar
• Export Citation

Meza R, Jeon J, Toumazis I, et al. Evaluation of the benefits and harms of lung cancer screening with low-dose computed tomography: modeling study for the US Preventive Services Task Force. JAMA 2021;325:988–997.

• PubMed
Meza R, Jeon J, Toumazis I, Evaluation of the benefits and harms of lung cancer screening with low-dose computed tomography: modeling study for the US Preventive Services Task Force. JAMA 2021;325:988–997.)| false
• Search Google Scholar
• Export Citation

Tindle HA, Stevenson Duncan M, Greevy RA, et al. Lifetime smoking history and risk of lung cancer: results from the Framingham Heart Study. J Natl Cancer Inst 2018;110:1201–1207.

• PubMed
Tindle HA, Stevenson Duncan M, Greevy RA, Lifetime smoking history and risk of lung cancer: results from the Framingham Heart Study. J Natl Cancer Inst 2018;110:1201–1207.)| false
• Search Google Scholar
• Export Citation

Ebbert JO, Yang P, Vachon CM, et al. Lung cancer risk reduction after smoking cessation: observations from a prospective cohort of women. J Clin Oncol 2003;21:921–926.

• PubMed
Ebbert JO, Yang P, Vachon CM, Lung cancer risk reduction after smoking cessation: observations from a prospective cohort of women. J Clin Oncol 2003;21:921–926.)| false
• Search Google Scholar
• Export Citation

Yang P, Wang Y, Wampfler JA, et al. Trends in subpopulations at high risk for lung cancer. J Thorac Oncol 2016;11:194–202.

• PubMed
Yang P, Wang Y, Wampfler JA, Trends in subpopulations at high risk for lung cancer. J Thorac Oncol 2016;11:194–202.)| false
• Search Google Scholar
• Export Citation

McKee BJ, Hashim JA, French RJ, et al. Experience with a CT screening program for individuals at high risk for developing lung cancer. J Am Coll Radiol 2015;12:192–197.

• PubMed
McKee BJ, Hashim JA, French RJ, Experience with a CT screening program for individuals at high risk for developing lung cancer. J Am Coll Radiol 2015;12:192–197.)| false
• Search Google Scholar
• Export Citation

Wolf AMD, Oeffinger KC, Shih TY, et al. Screening for lung cancer: 2023 guideline update from the American Cancer Society. CA Cancer J Clin 2024;74:50–81.

• PubMed
Wolf AMD, Oeffinger KC, Shih TY, Screening for lung cancer: 2023 guideline update from the American Cancer Society. CA Cancer J Clin 2024;74:50–81.)| false
• Search Google Scholar
• Export Citation

Landy R, Cheung LC, Young CD, et al. Absolute lung cancer risk increases among individuals with >15 quit-years: analyses to inform the update of the American Cancer Society lung cancer screening guidelines. Cancer 2024;130:201–215.

• PubMed
Landy R, Cheung LC, Young CD, Absolute lung cancer risk increases among individuals with >15 quit-years: analyses to inform the update of the American Cancer Society lung cancer screening guidelines. Cancer 2024;130:201–215.)| false
• Search Google Scholar
• Export Citation

Meza R, Cao P, de Nijs K, et al. Assessing the impact of increasing lung screening eligibility by relaxing the maximum years-since-quit threshold: a simulation modeling study. Cancer 2024;130:244–255.

• PubMed
Meza R, Cao P, de Nijs K, Assessing the impact of increasing lung screening eligibility by relaxing the maximum years-since-quit threshold: a simulation modeling study. Cancer 2024;130:244–255.)| false
• Search Google Scholar
• Export Citation

Kondo KK, Rahman B, Ayers CK, et al. Lung cancer diagnosis and mortality beyond 15 years since quit in individuals with a 20+ pack-year history: a systematic review. CA Cancer J Clin 2024;74:84–114.

• PubMed
Kondo KK, Rahman B, Ayers CK, Lung cancer diagnosis and mortality beyond 15 years since quit in individuals with a 20+ pack-year history: a systematic review. CA Cancer J Clin 2024;74:84–114.)| false
• Search Google Scholar
• Export Citation

Aberle DR, Adams AM, Berg CD, et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 2011;365:395–409.

• PubMed
Aberle DR, Adams AM, Berg CD, Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 2011;365:395–409.)| false
• Search Google Scholar
• Export Citation

Kavanagh J, Liu G, Menezes R, et al. Importance of long-term low-dose CT follow-up after negative findings at previous lung cancer screening. Radiology 2018;289:218–224.

• PubMed
Kavanagh J, Liu G, Menezes R, Importance of long-term low-dose CT follow-up after negative findings at previous lung cancer screening. Radiology 2018;289:218–224.)| false
• Search Google Scholar
• Export Citation

Tammemagi MC, Ten Haaf K, Toumazis I, et al. Development and validation of a multivariable lung cancer risk prediction model that includes low-dose computed tomography screening results: a secondary analysis of data from the National Lung Screening Trial. JAMA Netw Open 2019;2:e190204.

• PubMed
Tammemagi MC, Ten Haaf K, Toumazis I, Development and validation of a multivariable lung cancer risk prediction model that includes low-dose computed tomography screening results: a secondary analysis of data from the National Lung Screening Trial. JAMA Netw Open 2019;2:e190204.)| false
• Search Google Scholar
• Export Citation

Surveillance Research Program, National Cancer Institute. SEER*Explorer: an interactive website for SEER cancer statistics. Accessed November 21, 2024. Available at: https://seer.cancer.gov/statistics-network/explorer/

• PubMed
Surveillance Research Program, National Cancer Institute. SEER*Explorer: an interactive website for SEER cancer statistics. Accessed November 21, 2024. Available at: https://seer.cancer.gov/statistics-network/explorer/)| false
• Search Google Scholar
• Export Citation

Pinsky PF, Gierada DS, Hocking W, et al. National Lung Screening Trial findings by age: Medicare-eligible versus under-65 population. Ann Intern Med 2014;161:627–633.

• PubMed
Pinsky PF, Gierada DS, Hocking W, National Lung Screening Trial findings by age: Medicare-eligible versus under-65 population. Ann Intern Med 2014;161:627–633.)| false
• Search Google Scholar
• Export Citation

Katki HA, Kovalchik SA, Berg CD, et al. Development and validation of risk models to select ever-smokers for CT lung cancer screening. JAMA 2016;315:2300–2311.

• PubMed
Katki HA, Kovalchik SA, Berg CD, Development and validation of risk models to select ever-smokers for CT lung cancer screening. JAMA 2016;315:2300–2311.)| false
• Search Google Scholar
• Export Citation

Han SS, Ten Haaf K, Hazelton WD, et al. The impact of overdiagnosis on the selection of efficient lung cancer screening strategies. Int J Cancer 2017;140:2436–2443.

• PubMed
Han SS, Ten Haaf K, Hazelton WD, The impact of overdiagnosis on the selection of efficient lung cancer screening strategies. Int J Cancer 2017;140:2436–2443.)| false
• Search Google Scholar
• Export Citation

Criss SD, Cao P, Bastani M, et al. Cost-effectiveness analysis of lung cancer screening in the United States: a comparative modeling study. Ann Intern Med 2019;171:796–804.

• PubMed
Criss SD, Cao P, Bastani M, Cost-effectiveness analysis of lung cancer screening in the United States: a comparative modeling study. Ann Intern Med 2019;171:796–804.)| false
• Search Google Scholar
• Export Citation

Sox HC. Better evidence about screening for lung cancer. N Engl J Med 2011;365:455–457.

• PubMed
Sox HC. Better evidence about screening for lung cancer. N Engl J Med 2011;365:455–457.)| false
• Search Google Scholar
• Export Citation

Walter JE, Heuvelmans MA, de Jong PA, et al. Occurrence and lung cancer probability of new solid nodules at incidence screening with low-dose CT: analysis of data from the randomised, controlled NELSON trial. Lancet Oncol 2016;17:907–916.

• PubMed
Walter JE, Heuvelmans MA, de Jong PA, Occurrence and lung cancer probability of new solid nodules at incidence screening with low-dose CT: analysis of data from the randomised, controlled NELSON trial. Lancet Oncol 2016;17:907–916.)| false
• Search Google Scholar
• Export Citation

Office of the Surgeon General (US), Office on Smoking and Health (US). The Health Consequences of Smoking: a Report of the Surgeon General. Centers for Disease Control and Prevention (US); 2004.

• PubMed
Office of the Surgeon General (US), Office on Smoking and Health (US). The Health Consequences of Smoking: a Report of the Surgeon General. Centers for Disease Control and Prevention (US); 2004.)| false
• Search Google Scholar
• Export Citation

Centers for Disease Control and Prevention. Smoking-attributable mortality, years of potential life lost, and productivity losses–United States, 2000–2004. MMWR Morb Mortal Wkly Rep 2008;57:1226–1228.

• PubMed
Centers for Disease Control and Prevention. Smoking-attributable mortality, years of potential life lost, and productivity losses–United States, 2000–2004. MMWR Morb Mortal Wkly Rep 2008;57:1226–1228.)| false
• Search Google Scholar
• Export Citation

Jha P, Ramasundarahettige C, Landsman V, et al. 21st-century hazards of smoking and benefits of cessation in the United States. N Engl J Med 2013;368:341–350.

• PubMed
Jha P, Ramasundarahettige C, Landsman V, 21st-century hazards of smoking and benefits of cessation in the United States. N Engl J Med 2013;368:341–350.)| false
• Search Google Scholar
• Export Citation

Moolgavkar SH, Holford TR, Levy DT, et al. Impact of reduced tobacco smoking on lung cancer mortality in the United States during 1975–2000. J Natl Cancer Inst 2012;104:541–548.

• PubMed
Moolgavkar SH, Holford TR, Levy DT, Impact of reduced tobacco smoking on lung cancer mortality in the United States during 1975–2000. J Natl Cancer Inst 2012;104:541–548.)| false
• Search Google Scholar
• Export Citation

Potter AL, Xu NN, Senthil P, et al. Pack-year smoking history: an inadequate and biased measure to determine lung cancer screening eligibility. J Clin Oncol 2024;42:2026–2037.

• PubMed
Potter AL, Xu NN, Senthil P, Pack-year smoking history: an inadequate and biased measure to determine lung cancer screening eligibility. J Clin Oncol 2024;42:2026–2037.)| false
• Search Google Scholar
• Export Citation

Centers for Medicare & Medicaid Services. Eligible Professional Meaningful Use Core Measures, Measure 9 of 13. Accessed October 23, 2024. Available at: https://www.cms.gov/Regulations-and-Guidance/Legislation/EHRIncentivePrograms/downloads/9_Record_Smoking_Status.pdf

• PubMed
Centers for Medicare & Medicaid Services. Eligible Professional Meaningful Use Core Measures, Measure 9 of 13. Accessed October 23, 2024. Available at: https://www.cms.gov/Regulations-and-Guidance/Legislation/EHRIncentivePrograms/downloads/9_Record_Smoking_Status.pdf)| false
• Search Google Scholar
• Export Citation

Donnelly EF, Kazerooni EA, Lee E, et al. ACR Appropriateness Criteria® Lung Cancer Screening. J Am Coll Radiol 2018;15:S341–346.

• PubMed
Donnelly EF, Kazerooni EA, Lee E, et al. ACR Appropriateness Criteria^® Lung Cancer Screening. J Am Coll Radiol 2018;15:S341–346.)| false
• Search Google Scholar
• Export Citation

Bach PB, Mirkin JN, Oliver TK, et al. Benefits and harms of CT screening for lung cancer: a systematic review. JAMA 2012;307:2418–2429.

• PubMed
Bach PB, Mirkin JN, Oliver TK, Benefits and harms of CT screening for lung cancer: a systematic review. JAMA 2012;307:2418–2429.)| false
• Search Google Scholar
• Export Citation

Berrington de Gonzalez A, Kim KP, Berg CD. Low-dose lung computed tomography screening before age 55: estimates of the mortality reduction required to outweigh the radiation-induced cancer risk. J Med Screen 2008;15:153–158.

• PubMed
Berrington de Gonzalez A, Kim KP, Berg CD. Low-dose lung computed tomography screening before age 55: estimates of the mortality reduction required to outweigh the radiation-induced cancer risk. J Med Screen 2008;15:153–158.)| false
• Search Google Scholar
• Export Citation

American Lung Association. Why lung cancer screening isn’t for everyone. Accessed November 21, 2024. Available at: https://www.lung.org/blog/why-lung-cancer-screening

• PubMed
American Lung Association. Why lung cancer screening isn’t for everyone. Accessed November 21, 2024. Available at: https://www.lung.org/blog/why-lung-cancer-screening)| false
• Search Google Scholar
• Export Citation

Riely GJ, Wood DE, Ettinger DS, et al. NCCN Clinical Practice Guidelines in Oncology: Non-Small Cell Lung Cancer, Version 4.2024 Accessed November 21, 2024. To view the most recent version, visit https://www.nccn.org/

• PubMed
Riely GJ, Wood DE, Ettinger DS, NCCN Clinical Practice Guidelines in Oncology: Non-Small Cell Lung Cancer, Version 4.2024 Accessed November 21, 2024. To view the most recent version, visit https://www.nccn.org/)| false
• Search Google Scholar
• Export Citation

Sands J, Tammemagi MC, Couraud S, et al. Lung screening benefits and challenges: a review of the data and outline for implementation. J Thorac Oncol 2021;16:37–53.

• PubMed
Sands J, Tammemagi MC, Couraud S, Lung screening benefits and challenges: a review of the data and outline for implementation. J Thorac Oncol 2021;16:37–53.)| false
• Search Google Scholar
• Export Citation

Becker N, Motsch E, Trotter A, et al. Lung cancer mortality reduction by LDCT screening –results from the randomized German LUSI trial. Int J Cancer 2020;146:1503–1513.

• PubMed
Becker N, Motsch E, Trotter A, Lung cancer mortality reduction by LDCT screening –results from the randomized German LUSI trial. Int J Cancer 2020;146:1503–1513.)| false
• Search Google Scholar
• Export Citation

Detterbeck FC. Overdiagnosis during lung cancer screening: is it an overemphasised, underappreciated, or tangential issue? Thorax 2014;69:407–408.

• PubMed
Detterbeck FC. Overdiagnosis during lung cancer screening: is it an overemphasised, underappreciated, or tangential issue? Thorax 2014;69:407–408.)| false
• Search Google Scholar
• Export Citation

Huo J, Xu Y, Sheu T, et al. Complication rates and downstream medical costs associated with invasive diagnostic procedures for lung abnormalities in the community setting. JAMA Intern Med 2019;179:324–332.

• PubMed
Huo J, Xu Y, Sheu T, Complication rates and downstream medical costs associated with invasive diagnostic procedures for lung abnormalities in the community setting. JAMA Intern Med 2019;179:324–332.)| false
• Search Google Scholar
• Export Citation

Yang S, Shih YT, Huo J, et al. Procedural complications associated with invasive diagnostic procedures after lung cancer screening with low-dose computed tomography. Lung Cancer 2022;165:141–144.

• PubMed
Yang S, Shih YT, Huo J, Procedural complications associated with invasive diagnostic procedures after lung cancer screening with low-dose computed tomography. Lung Cancer 2022;165:141–144.)| false
• Search Google Scholar
• Export Citation

Tailor TD, Bell S, Fendrick AM, Carlos RC. Total and out-of-pocket costs of procedures after lung cancer screening in a national commercially insured population: estimating an episode of care. J Am Coll Radiol 2022;19:35–46.

• PubMed
Tailor TD, Bell S, Fendrick AM, Carlos RC. Total and out-of-pocket costs of procedures after lung cancer screening in a national commercially insured population: estimating an episode of care. J Am Coll Radiol 2022;19:35–46.)| false
• Search Google Scholar
• Export Citation

Rampinelli C, De Marco P, Origgi D, et al. Exposure to low dose computed tomography for lung cancer screening and risk of cancer: secondary analysis of trial data and risk-benefit analysis. BMJ 2017;356:j347.

• PubMed
Rampinelli C, De Marco P, Origgi D, Exposure to low dose computed tomography for lung cancer screening and risk of cancer: secondary analysis of trial data and risk-benefit analysis. BMJ 2017;356:j347.)| false
• Search Google Scholar
• Export Citation

Wiener RS. Balancing the benefits and harms of low-dose computed tomography screening for lung cancer: Medicare's options for coverage. Ann Intern Med 2014;161:445–446.

• PubMed
Wiener RS. Balancing the benefits and harms of low-dose computed tomography screening for lung cancer: Medicare's options for coverage. Ann Intern Med 2014;161:445–446.)| false
• Search Google Scholar
• Export Citation

Braillon A. Bronchioalveolar lung cancer: screening and overdiagnosis. J Clin Oncol 2014;32:3575.

• PubMed
Braillon A. Bronchioalveolar lung cancer: screening and overdiagnosis. J Clin Oncol 2014;32:3575.)| false
• Search Google Scholar
• Export Citation

Lillie SE, Fu SS, Fabbrini AE, et al. What factors do patients consider most important in making lung cancer screening decisions? Findings from a demonstration project conducted in the Veterans Health Administration. Lung Cancer 2017;104:38–44.

• PubMed
Lillie SE, Fu SS, Fabbrini AE, What factors do patients consider most important in making lung cancer screening decisions? Findings from a demonstration project conducted in the Veterans Health Administration. Lung Cancer 2017;104:38–44.)| false
• Search Google Scholar
• Export Citation

Woloshin S, Schwartz LM, Black WC, Kramer BS. Cancer screening campaigns–getting past uninformative persuasion. N Engl J Med 2012;367:1677–1679.

• PubMed
Woloshin S, Schwartz LM, Black WC, Kramer BS. Cancer screening campaigns–getting past uninformative persuasion. N Engl J Med 2012;367:1677–1679.)| false
• Search Google Scholar
• Export Citation

de Koning HJ, Meza R, Plevritis SK, et al. Benefits and harms of computed tomography lung cancer screening strategies: a comparative modeling study for the U.S. Preventive Services Task Force. Ann Intern Med 2014;160:311–320.

• PubMed
de Koning HJ, Meza R, Plevritis SK, Benefits and harms of computed tomography lung cancer screening strategies: a comparative modeling study for the U.S. Preventive Services Task Force. Ann Intern Med 2014;160:311–320.)| false
• Search Google Scholar
• Export Citation

Sox HC. Implementing lung cancer screening under Medicare: the last chance to get it right? JAMA 2014;312:1206–1207.

• PubMed
Sox HC. Implementing lung cancer screening under Medicare: the last chance to get it right? JAMA 2014;312:1206–1207.)| false
• Search Google Scholar
• Export Citation

Volk RJ, Hawk E, Bevers TB. Should CMS cover lung cancer screening for the fully informed patient? JAMA 2014;312:1193–1194.

• PubMed
Volk RJ, Hawk E, Bevers TB. Should CMS cover lung cancer screening for the fully informed patient? JAMA 2014;312:1193–1194.)| false
• Search Google Scholar
• Export Citation

Tammemagi MC, Schmidt H, Martel S, et al. Participant selection for lung cancer screening by risk modelling (the Pan-Canadian Early Detection of Lung Cancer [PanCan] study): a single-arm, prospective study. Lancet Oncol 2017;18:1523–1531.

• PubMed
Tammemagi MC, Schmidt H, Martel S, Participant selection for lung cancer screening by risk modelling (the Pan-Canadian Early Detection of Lung Cancer [PanCan] study): a single-arm, prospective study. Lancet Oncol 2017;18:1523–1531.)| false
• Search Google Scholar
• Export Citation

Herder GJ, van Tinteren H, Golding RP, et al. Clinical prediction model to characterize pulmonary nodules: validation and added value of 18F-fluorodeoxyglucose positron emission tomography. Chest 2005;128:2490–2496.

• PubMed
Herder GJ, van Tinteren H, Golding RP, Clinical prediction model to characterize pulmonary nodules: validation and added value of 18F-fluorodeoxyglucose positron emission tomography. Chest 2005;128:2490–2496.)| false
• Search Google Scholar
• Export Citation

Tammemagi MC, Church TR, Hocking WG, et al. Evaluation of the lung cancer risks at which to screen ever- and never-smokers: screening rules applied to the PLCO and NLST cohorts. PLoS Med 2014;11:e1001764.

• PubMed
Tammemagi MC, Church TR, Hocking WG, Evaluation of the lung cancer risks at which to screen ever- and never-smokers: screening rules applied to the PLCO and NLST cohorts. PLoS Med 2014;11:e1001764.)| false
• Search Google Scholar
• Export Citation

Yousaf-Khan U, van der Aalst C, de Jong PA, et al. Risk stratification based on screening history: the NELSON lung cancer screening study. Thorax 2017;72:819–824.

• PubMed
Yousaf-Khan U, van der Aalst C, de Jong PA, Risk stratification based on screening history: the NELSON lung cancer screening study. Thorax 2017;72:819–824.)| false
• Search Google Scholar
• Export Citation